| Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease OA Moore, N Goh, T Corte, H Rouse, O Hennessy, V Thakkar, J Byron, ... Rheumatology 52 (1), 155-160, 2013 | 201 | 2013 |
| N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study V Thakkar, WM Stevens, D Prior, OA Moore, J Byron, D Liew, K Patterson, ... Arthritis research & therapy 14, 1-10, 2012 | 127 | 2012 |
| A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis Y Hao, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, P Youssef, ... Arthritis research & therapy 17, 1-11, 2015 | 122 | 2015 |
| The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study V Thakkar, W Stevens, D Prior, P Youssef, D Liew, E Gabbay, J Roddy, ... Arthritis research & therapy 15, 1-11, 2013 | 88 | 2013 |
| Patients’ perspectives and experiences living with systemic sclerosis: a systematic review and thematic synthesis of qualitative studies A Nakayama, DJ Tunnicliffe, V Thakkar, D Singh-Grewal, S O’Neill, ... The Journal of rheumatology 43 (7), 1363-1375, 2016 | 83 | 2016 |
| Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease OA Moore, SM Proudman, N Goh, TJ Corte, H Rouse, O Hennessy, ... Clin Exp Rheumatol 33 (4 Suppl 91), S111-6, 2015 | 81 | 2015 |
| Connective tissue disease-related pulmonary arterial hypertension V Thakkar, EMT Lau Best Practice & Research Clinical Rheumatology 30 (1), 22-38, 2016 | 55 | 2016 |
| Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology EA Butler, M Baron, AB Fogo, T Frech, C Ghossein, E Hachulla, S Hoa, ... Arthritis & rheumatology 71 (6), 964-971, 2019 | 48 | 2019 |
| “It's not me, it's not really me.” Insights from patients on living with systemic sclerosis: an interview study D Sumpton, V Thakkar, S O'Neill, D Singh‐Grewal, JC Craig, A Tong Arthritis care & research 69 (11), 1733-1742, 2017 | 47 | 2017 |
| Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality N Richard, M Hudson, M Wang, G Gyger, S Proudman, W Stevens, ... Rheumatology 58 (4), 636-644, 2019 | 40 | 2019 |
| The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis KB Morrisroe, W Stevens, H Nandurkar, D Prior, V Thakkar, J Roddy, ... Clin Exp Rheumatol 32 (6 Suppl 86), 133-7, 2014 | 39 | 2014 |
| Survival of idiopathic pulmonary arterial hypertension patients in the modern era in Australia and New Zealand G Strange, EM Lau, E Giannoulatou, C Corrigan, E Kotlyar, F Kermeen, ... Heart, Lung and Circulation 27 (11), 1368-1375, 2018 | 34 | 2018 |
| Retrospective validation of the REVEAL 2.0 risk score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort JJ Anderson, EM Lau, M Lavender, R Benza, DS Celermajer, N Collins, ... Chest 157 (1), 162-172, 2020 | 30 | 2020 |
| Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis A Quinlivan, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, ... Internal medicine journal 45 (11), 1134-1140, 2015 | 26 | 2015 |
| The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related … V Thakkar, W Stevens, D Prior, C Rabusa, J Sahhar, JG Walker, J Roddy, ... Clin Exp Rheumatol 34 (Suppl 100), 129-136, 2016 | 22 | 2016 |
| Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations V Thakkar, KA Patterson, W Stevens, M Wilson, J Roddy, J Sahhar, ... Clinical Rheumatology 37, 1563-1571, 2018 | 21 | 2018 |
| Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol A Calderone, W Stevens, D Prior, H Nandurkar, E Gabbay, SM Proudman, ... BMJ open 6 (12), e011028, 2016 | 20 | 2016 |
| Performance of screening algorithms in systemic sclerosis‐related pulmonary arterial hypertension: a systematic review V Thakkar, WM Stevens, OA Moore, M Nikpour Internal Medicine Journal 43 (7), 751-760, 2013 | 17 | 2013 |
| Prospects for improving outcomes in systemic sclerosis‐related pulmonary hypertension V Thakkar, M Nikpour, WM Stevens, SM Proudman Internal Medicine Journal 45 (3), 248-254, 2015 | 12 | 2015 |
| Scope and consistency of outcomes reported in trials of patients with systemic sclerosis D Sumpton, A Bigot, B Sautenet, JC Craig, G Hassett, V Thakkar, ... Arthritis Care & Research 72 (10), 1449-1458, 2020 | 10 | 2020 |
